Contact this trialFirst, we need to learn more about you.
Corticosteroid
Loteprednol Etabonate for Corneal Edema
Recruiting3 awardsPhase 4
Indianapolis, Indiana
This trial is testing whether loteprednol etabonate 0.25% ophthalmic suspension (Eysuvis) is effective in preventing immunologic rejection in the first year after Descemet membrane endothelial keratoplasty (DMEK).
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.